Drug Type Small molecule drug |
Synonyms |
Target |
Action activators |
Mechanism NAMPT activators(Nicotinamide phosphoribosyltransferase activators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC20H16N4O2 |
InChIKeyUUEQAVONCDUZBA-UHFFFAOYSA-N |
CAS Registry2408307-79-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Obesity | Preclinical | Japan | 01 Nov 2021 |